While following the emotional crowd may take away the pain for a short while, Frank Kollar of Fibtimer.com doesn't think it is the path to profit. Instead, Frank uses a literary analogy to explain why he feels that only those traders committed to following an unemotional timing strategy will stay the course.
For the benefit of all newbies questioning whether or not they are really cut out for trading, John Forman of The Essentials of Trading extrapolates on a colleague's post about a trio of warning signals to watch out for, each of which could be very telling.
For the longer run, we believe foreign developed markets, especially much of Continental Europe and Japan, face headwinds that will restrain growth and, thus, stock prices, asserts Mark Salzinger, editor The No-Load Fund Investor.
Gerardo Del Real, a leading metals and mining expert, recently launched the Resource Stock Digest. In December, he had rare opportunity to interview the legendary James Dines.
The S&P Dividend Aristocrats is a list of S&P 500 stocks that have increased their dividends for at least 25 consecutive years. Typically around 50 stocks make the list, which is updated at the beginning of each year, observes Harry Domash, editor of Dividend Detective.
Box (BOX) is a small, rapidly growing company that's taking advantage of the broad-based shift to the cloud, asserts growth expert Mike Cintolo, editor of Cabot Top Ten Trader.
We are upgrading our rating on Royal Caribbean Cruises Ltd. (RCL) to "buy" with a target of $116 per share, asserts John Staszak of Argus Research.
Our long held theory is that excessive growth in the utilization of derivatives has added greatly to systemic risk and has impeded long term economic growth, cautions Alan Newman, editor of CrossCurrents.
Human nature being what it is, the temptation is always great to buy last year's "winning" funds and to sell your losers, suggests mutual fund expert Jack Bowers, editor of Fidelity Monitor & Insight.
Intrexon (XON) has made a small yet strategic acquisition in buying GenVec (GNVC); with the purchase, XON gets AdenoVerse, a platform of adenovirus vectors for delivering drugs and vaccines that dovetails nicely with its existing suite of gene therapy technologies, suggests John McCamant, editor of The Medical Technology Stock Letter.
For investors who may wish to make a more speculative investment, I have a company that could profit handsomely from one of President Trump's biggest promises: to build a wall between the US and Mexico, notes Jim Powell, editor of Global Changes & Opportunities Report.
John Buckingham, editor of The Prudent Speculator, focuses on a widely-diversified portfolio of value-oriented stocks; here, he reviews two leading pharmaceutical firms with promising drug development operations.
One sector that begins its seasonally favorable periods in March is utilities, explains Jeffrey Hirsch, seasonal timing expert and editor of Stock Trader's Almanac.
Money is flowing into precious metals and the price action is strong. It looks like a classic "flight to safety" that should have some legs, explains Moby Waller, editor of Daily Profit.
Join thousands of your fellow investors and traders in Orlando for a four-day event that will have a substantial impact on your success in today's volatile markets.
Daily Market Studies with Dan Gramza provides insights, considerations, and implications for trading futures and options on stock indexes, forex, grains, precious metals, and more.
What two factors have created recessions? How the co-founder of MoneyTrader.com spots higher highs and higher lows as the markets react to the new Donald Trump Administration.
MoneyShow Orlando "is the highlight of my financial season to come and see so many prominent people," says this third time participant.
Among the stocks and mutuals that he likes: American Express (AXP), Franklin Resources (BEN), T. Rowe Price (TROW), Cummins (CMI), Fluor (FLR), Union Pacific (UNP). He tells Nancy Zambell why.
What can dividends show you these days? "Dividends provide a floor safety underneath the stock. It tells us the company is making money.
For a guide to how the markets react to President Trump, he suggests looking back. "I think back to 1981 when Ronald Reagan was elected.
"The good news is that bull markets don't die from old age," says the president of InvesTech Research and Stack Financial Management. Warning flags?
"We like healthcare a lot," says the editor of the Forbes Real Estate Investor newsletter. "Healthcare is obviously fueled by the aging population." He shares some picks
What's the value of Donald Trump's real estate holdings worldwide? Ask the editor who has visited every property. Thomas wrote...
How does 2017 look for Real Estate Investment Trusts? Well, "now that we've got a president who understands real estate…" says the editor of Forbes Real Estate Investor.